Join us on November 5th and 6th for the world’s largest educational symposium on chronic obstructive pulmonary disease (COPD). The upcoming GOLD International COPD Conference is once again a two-day event hosted in Philadelphia, Pennsylvania.
New for 2026:
Expanded Specialty-Targeted
Pre-Conference Sessions!
Both days will be presented in a hybrid format with in-person sessions virtually simulcast to a global audience of healthcare providers involved in the care and management of people with COPD. In-person attendance includes meals, refreshments, product theaters, sponsored sessions, and access to the exhibit hall. Both in-person and virtual registration will also include access to the on-demand library for one year following the conference.
Philadelphia: A global destination in a landmark year.
This fall, connect with your COPD colleagues in Philadelphia! Philly is one of the world’s most dynamic cities, and has been named one of the top cities in the world to visit in 2026 by Travel + Leisure, The New York Times, the BBC, and more.
As the city hosts several once-in-a-lifetime events throughout 2026, it offers GOLD attendees an exceptional opportunity to connect, explore, and experience a city where innovation, science, and history intersect. Visit the "Welcome to Philadelphia!" tab to learn more about the area.
The 2026 GOLD International COPD Conference is hosted by the Global Initiative for Chronic Obstructive Lung Disease (GOLD) in partnership with The Temple Lung Center.
The Global Initiative for Chronic Obstructive Lung Disease (GOLD) works with healthcare professionals and public health officials around the world to raise awareness of COPD and to improve prevention and treatment of this lung disease. Through the development of evidence-based strategy documents for the management of COPD, and annual events such as World COPD Day and the GOLD International COPD Conference, GOLD is working to improve the lives of people with COPD in every corner of the globe.
GOLD was launched in 1997 in collaboration with the National Heart, Lung, and Blood Institute, National Institutes of Health, USA, and the World Health Organization. GOLD’s program is determined and its guidelines for COPD care are shaped by committees made up of leading experts from around the world.
The Temple Lung Center is a national leader in the clinical care of advanced lung disease. As a national hub for research, The TLC is actively involved in the advancement of lung disease treatment, harnessing innovation and expertise to discover tomorrow’s standard of care.
The Temple Lung Center is part of Temple Health — a $1.6 billion academic health system dedicated to providing access to quality patient care and supporting excellence in medical education and research. Located in Philadelphia, Pennsylvania, the lung center is comprised of pulmonary, critical care and sleep medicine; lung transplant; and thoracic surgery, and works closely with the Center for Inflammation and Lung Research at the Lewis Katz School of Medicine at Temple University.
This CME (ACCME/CRCE) activity is provided by Integrity CE, LLC.
This CE activity for Joint Accreditation, ANCC and ACPE credit, is jointly provided by Global Education Group (Global) and Integrity CE, LLC.
This activity is supported by an educational grant from Chiesi USA, Inc.
For information about the event, please contact Integrity CE, LLC at 855-835-4004 or goldcopd@integrityce.com.